Article
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
Clinical Pharmacology: Advances and Applications · 2016 · Munir KM, Davis SN
Key facts
| Title | Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes |
|---|---|
| First author | Munir KM, Davis SN |
| Journal | Clinical Pharmacology: Advances and Applications |
| Published | Apr 20, 2016 |
| DOI | 10.2147/CPAA.S77754 |
| Devices mentioned | 212264 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1